Used in cancer research due to its ability to induce apoptosis in tumor cells by targeting the Mcl-1 protein, an anti-apoptotic factor overexpressed in many cancers. Shows potent activity against drug-resistant cancer cell lines, particularly in leukemia and myeloma models. Investigated for its potential in combination therapies to enhance the effectiveness of existing chemotherapeutic agents. Also studied for antibacterial properties, especially against methicillin-resistant Staphylococcus aureus (MRSA), making it a dual-interest compound in oncology and infectious disease research.